New program aims to curb antibiotic overuse in nursing homes
NCT ID NCT07246382
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a customizable program called ORANEAT to help French nursing homes use antibiotics more responsibly. The program includes a check of current practices, a toolkit of actions, and support from local experts. Researchers will compare antibiotic use in 66 nursing homes that use the program versus those that don't, to see if it works and can be sustained.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- customizable antibiotic stewardship program (ORANEAT)
- What this could lead to
- If successful, this could provide an effective, adaptable program to reduce antibiotic overuse in nursing homes, helping fight antibiotic resistance.
- What could go wrong
- This is a small, early-stage study in specific French regions, so results may not apply elsewhere. The program's complexity may also make it hard to implement consistently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 66 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Nursing homes Inclusion criteria: • Nursing home located in one of the geographical areas participating in the study in two French regions (i.e., geographical areas covered by experts in antibiotic stewardship and/or in infection prevention and control who agreed to participate in the study) Exclusion criteria: * Nursing home with a pharmacy for internal use * Participation to the pilot study * Data from the Health Insurance reimbursement database (Système national des données de santé) not available on the study period * Refusal of the nursing director to participate in the study (for Arm 1 only) Residents (Outcomes 1 to 4 and outcome 12) Inclusion criteria: • Resident aged 18 or more who had lived in one of the participating nursing homes during the study period. Exclusion criteria: / Healthcare professionals (Outcomes 11, 13 and 15) Inclusion criteria: • Healthcare professionals aged 18 or more working in one of the participating nursing homes from Arm 1 (including healthcare professionals who provide services to or collaborate with the nursing home even if they are not on-site, e.g., private general practitioners, community pharmacists, microbiologists, and professionals responsible for the implementation support). Exclusion criteria: • Refusal to complete the self-administered questionnaires or to participate in qualitative investigations.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Antibacterial agents are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.